Semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound) have transformed medical weight loss. Patients are achieving remarkable, sustained fat reduction. However, a significant weight loss journey often reveals two aesthetic challenges: stubborn fat pockets  that resist the medication, and the crucial need to maintain muscle tone  and skin firmness . This leads to the question we hear most often from our successful patients: When is the right time to transition f

Your Clinic-Supervised Strategy for GLP-1 Side Effect Management Starting treatment with GLP-1 receptor agonists like Semaglutide  (Ozempic/Wegovy) and Tirzepatide  (Mounjaro/Zepbound) is an exciting step toward better health. These dual-acting medications are highly effective because they mimic natural gut hormones to slow gastric emptying, regulate appetite, and control blood sugar. However, it is this very mechanism—slowing down digestion—that causes the majority of initia